Inventor · Ivanhoe, AU

Jonathan Bayldon Baell

28Patents
7h-index
67Co-inventors
68Inventor score

Filing activity: Sep 10, 1999 → Mar 29, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US8114893B2 Compounds and methods of use Chemistry; Metallurgy 42 Active
US8168645B2 Arylsulfonamide compounds Human Necessities 31 Active
US8518970B2 Compounds and methods of use Chemistry; Metallurgy 28 Active
US8232273B2 Heterocyclic compounds and methods of use Chemistry; Metallurgy 26 Active
US6355683B1 Fc receptor modulators and uses thereof Emerging Cross-Sectional Technologies 19 Expired
US8293737B2 Anxiolytic compounds Human Necessities 10 Active
US6835753B2 Fc receptor modulators and uses thereof Emerging Cross-Sectional Technologies 8 Expired
US8614212B2 Anxiolytic compounds Human Necessities 7 Active
US8551990B2 Anxiolytic compounds Human Necessities 7 Active
US8906912B2 Anxiolytic compounds Human Necessities 5 Active
US9067928B2 Compounds and methods of use Chemistry; Metallurgy 5 Active
US9023848B2 Small-molecules as therapeutics Chemistry; Metallurgy 4 Active
US9573945B2 Anxiolytic compounds Human Necessities 3 Active
US7553809B2 Fc receptor modulators and uses thereof Human Necessities 3 Expired
US8202513B2 Aryl potassium channel blockers and uses thereof Chemistry; Metallurgy 1 Active
US10233181B2 Anxiolytic compounds Human Necessities 1 Active
US10954231B2 Anxiolytic compounds Human Necessities 1 Active
US9975892B2 Anxiolytic compounds Human Necessities 1 Active
US11208404B2 Compounds useful as inhibitors of ALCAT 1 Chemistry; Metallurgy 0 Active
US8507539B2 Potassium channel blockers and uses thereof Chemistry; Metallurgy 0 Active
US8063093B2 Potassium channel blockers and uses thereof Chemistry; Metallurgy 0 Active
US7956216B2 Alpha-helical mimetics Chemistry; Metallurgy 0 Active
US7507839B2 Therapeutic ion channel blocking agents and methods of use thereof Chemistry; Metallurgy 0 Expired
US10829446B2 Aryl sulfonohydrazides Chemistry; Metallurgy 0 Active
US8962830B2 Protein kinase inhibitors and methods of treatment Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.